UTHR is a biotech company. It closed at $127.92. There are rumors that GSK and GILD are competing to buy the company at around $200. Based on rumors the stock has moved up to $138 in the pre-market.
Consider accumulating up to 25% of the full core position size on any dip in the zone of $126 to $135.52. Consider scaling in in the smallest tranche that your account will allow as the stock can trade in a very wide range. Stop zone is $113 to $117.43.
This is suitable only for aggressive investors as the risk of loss is high.